FSMA Food Safety Violations: How FDA Enforces Preventive Controls
Last updated: 2026-04-06 — ComplianceStack Editorial Team
The Food Safety Modernization Act shifted FDA from reactive enforcement to a preventive controls framework. Under 21 CFR Part 117, every food facility must conduct a hazard analysis, implement risk-based preventive controls, and maintain written food safety plans. When FDA inspectors find violations, enforcement escalates through a predictable path: observations on Form 483, warning letters demanding corrective action, re-inspections with mandatory fees ($318/hour in FY2025), facility registration suspension, product seizure, consent decrees, and ultimately criminal prosecution. Between 2017 and 2023, FDA issued 186 warning letters for food cGMP and preventive controls violations — 149 to human food facilities and 37 to animal food facilities. Understanding where your facility sits on this escalation ladder is the difference between a correctable finding and a shutdown.
Penalty Tier Breakdown
Form 483 Observations — Inspection Findings
No direct fine — triggers corrective action timelineFDA inspectors document objectionable conditions on Form 483 at the end of an inspection. Form 483 observations are not formal enforcement actions — they are findings that require the facility to respond with a corrective action plan. However, failure to respond or inadequate response triggers a warning letter. FDA considers non-response a significant aggravating factor in all subsequent enforcement.
Warning Letter — Formal Enforcement Notice
No direct fine — but triggers re-inspection fees of $318/hour (FY2025) and heightened scrutinyWarning letters are FDA's primary enforcement tool for significant FSMA violations. They cite specific regulatory provisions violated, demand immediate corrective action, and put the facility on an accelerated re-inspection schedule. The facility must pay re-inspection fees at $318 per direct work hour (FY2025 rate, $340/hour with domestic travel, $373/hour with foreign travel). FDA issued FSMA-related warning letters at an increasing rate through 2023–2024, with particular focus on preventive controls failures and inadequate hazard analyses.
Facility Registration Suspension — Operational Shutdown
Facility cannot legally manufacture, process, pack, or distribute food in the United StatesUnder FSMA Section 102 (21 USC 350d), FDA can suspend a facility's food facility registration when there is a reasonable probability that food manufactured, processed, packed, received, or held by the facility will cause serious adverse health consequences or death. Suspension is an immediate operational shutdown — the facility cannot legally offer food for sale in the United States until FDA lifts the suspension. Only the FDA Commissioner or HHS Secretary can issue a suspension order. This power was first granted by FSMA and represents FDA's most direct administrative enforcement tool.
Seizure, Injunction, and Consent Decree — Judicial Enforcement
Court-ordered: product seizure (total loss of inventory), permanent injunction, consent decree with ongoing FDA oversightWhen administrative actions fail, FDA works with the Department of Justice to pursue judicial enforcement. Product seizure (21 USC 334) allows FDA to remove adulterated or misbranded food from commerce. Injunctions (21 USC 332) are court orders that prohibit continued violations. Consent decrees — the most common outcome — are negotiated settlements where the company agrees to specific corrective actions, ongoing FDA oversight, and operational restrictions. Violating a consent decree triggers contempt of court proceedings. In March 2025, the U.S. District Court for the District of Maryland entered a consent decree against Totally Cool, Inc. and its CEO, prohibiting all food operations until specific FDA conditions are met.
How Penalties Are Calculated
FDA enforcement escalates through a defined sequence: Form 483 observations → warning letter → re-inspection with mandatory fees → facility registration suspension → seizure/injunction/consent decree → criminal prosecution. Re-inspection fees are set annually by Federal Register notice: FY2025 rates are $318 per direct work hour ($340 with domestic travel, $373 with foreign travel). Criminal penalties under the Federal Food, Drug, and Cosmetic Act (21 USC 333) range from misdemeanor charges (up to $1,000 fine and/or 1 year imprisonment for first offense) to felony charges (up to $10,000 and/or 3 years imprisonment for second offense or intent to defraud/mislead). Civil money penalties under 21 USC 333(f) can reach approximately $690,000 per individual and $7,000,000 per other persons (corporations) per proceeding, adjusted annually for inflation. The 2025 inflation multiplier is 1.02598. Factors affecting enforcement severity: history of violations, speed of corrective action, whether the violation caused actual illness or death, cooperation with FDA investigators, and whether the entity self-reported the problem.
Recent Enforcement Actions
Understand Your FDA/FSMA Penalty Exposure
Use ComplianceStack's free tools to identify gaps before regulators do.
Take the Quiz → Gap Analyzer →Frequently Asked Questions
Can FDA shut down a food facility immediately without a court order?
Yes — through facility registration suspension under FSMA Section 102. FDA can suspend a facility's registration administratively when there is reasonable probability that food at the facility will cause serious adverse health consequences or death. Suspension is immediate and does not require a court order. The facility cannot legally operate until FDA lifts the suspension. This is distinct from seizure or injunction, which require DOJ involvement and court orders. FDA used this power against Totally Cool, Inc. in June 2024, effectively shutting down the ice cream manufacturer after finding persistent Listeria contamination.
How much do FDA re-inspection fees cost?
For FY2025 (October 2024 – September 2025), re-inspection fees are $318 per direct work hour without travel, $340 per hour with domestic travel, and $373 per hour with foreign travel. These fees apply when FDA conducts a follow-up inspection to determine whether a facility has corrected violations identified in a previous inspection classified as Official Action Indicated (OAI). Fees are mandatory — facilities cannot decline to pay. A typical re-inspection lasting 40–80 hours costs $12,720–$25,440 before any travel costs. Rates are published annually in the Federal Register and adjusted for inflation.
What is the difference between a warning letter and a consent decree?
A warning letter is an administrative action — FDA notifies the facility of specific violations and demands corrective action, but it carries no direct financial penalty. A consent decree is a court-ordered agreement negotiated between the facility, DOJ, and FDA that typically prohibits continued operations until specific conditions are met, requires ongoing FDA oversight, mandates third-party audits, and imposes operational restrictions. Consent decrees are legally binding — violating one triggers contempt of court proceedings. Warning letters are the starting point; consent decrees come after a facility has failed to correct violations despite repeated warnings. Most facilities that reach the consent decree stage have a multi-year history of non-compliance.